Severe cutaneous adverse reactions related to systemic antibiotics

Clinical Infectious Diseases

Volumn 58, Issue 10, 2014, Pages 1377-1385

  Lin, Ying Fang ^a   Yang, Chih Hsun ^a,b   Sindy, Hu ^a,b   Lin, Jing Yi ^a,b   Hui, Chung Yee Rosaline ^a,b   Tsai, Yun Chen ^a   Wu, Ting Shu ^a   Huang, Ching Tai ^a   Kao, Kuo Chin ^a,b   Hu, Han Chung ^a,b   Chiu, Cheng Hsun ^a   Hung, Shuen Iu ^c   Chung, Wen Hung ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

SCARs; Systemic antibiotics

Indexed keywords

ANTIBIOTIC AGENT; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; PENICILLIN DERIVATIVE; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLONE DERIVATIVE; ANTIINFECTIVE AGENT; GLYCOPEPTIDE;

ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS; ADULT; ARTICLE; CLINICAL FEATURE; DISEASE SEVERITY; DRESS SYNDROME; DRUG SAFETY; DRUG TOLERABILITY; FATALITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEPSIS; STEVENS JOHNSON SYNDROME; TAIWAN; TOXIC EPIDERMAL NECROLYSIS; AGED; DRUG ERUPTIONS; EOSINOPHILIA; MIDDLE AGED; STEVENS-JOHNSON SYNDROME; VERY ELDERLY;

ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CARBAPENEMS; CEPHALOSPORINS; DRUG ERUPTIONS; EOSINOPHILIA; FEMALE; GLYCOPEPTIDES; HUMANS; MALE; MIDDLE AGED; PENICILLINS; QUINOLONES; RETROSPECTIVE STUDIES; STEVENS-JOHNSON SYNDROME; TAIWAN;

EID: 84899820572     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu126     Document Type: Article

References (32)

1. Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC.Clinical classification of cases of toxic epidermal necrolysisStevens-Johnson syndrome, and erythema multiforme. Arch Dermatol1993; 129:92-6.
2. Chan HL, Stern RS, Arndt KA, et al. The incidence of erythema multiforme,Stevens-Johnson syndrome, and toxic epidermal necrolysis: apopulation-based study with particular reference to reactions causedby drugs among outpatients. Arch Dermatol 1990; 126:43-7.
3. Di Pascuale MA, Espana EM, Liu DT, et al. Correlation of cornealcomplications with eyelid cicatricial pathologies in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis syndrome.Ophthalmology 2005; 112:904-12.
4. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. NEngl J Med 1994; 331:1272-85.
5. Posadas SJ, Pichler WJ. Delayed drug hypersensitivity reactions-newconcepts. Clin Exp Allergy 2007; 37:989-99.
6. Chung WH, Hung SI, Yang JY, et al. Granulysin is a key mediator fordisseminated keratinocyte death in Stevens-Johnson syndrome andtoxic epidermal necrolysis. Nat Med 2008; 14:1343-50.
7. Kardaun SH, Sidoroff A, Valeyrie-Allanore L, et al. Variability in theclinical pattern of cutaneous side-effects of drugs with systemic symptoms:does a DRESS syndrome really exist? Br J Dermatol 2007;156:609-11.
8. Sidoroff A, Halevy S, Bavinck JN, et al. Acute generalized exanthematouspustulosis (AGEP)-a clinical reaction pattern. J Cutan Pathol2001; 28:113-19.
9. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating theprobability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
10. Sassolas B, Haddad C, Mockenhaupt M, et al. ALDEN, an algorithm forassessment of drug causality in Stevens-Johnson syndrome and toxicepidermal necrolysis: comparison with case-control analysis. Clin PharmacolTher 2010; 88:60-8.
11. Bastuji-Garin S, Fouchard N, Bertocchi M, et al. SCORTEN: a severityof-illness score for toxic epidermal necrolysis. J Invest Dermatol 2000;115:149-53.
12. Thong BY. Update on the management of antibiotic allergy. AllergyAsthma Immunol Res 2010; 2:77-86.
13. Schneck J, Fagot JP, Sekula P, Sassolas B, Roujeau JC, Mockenhaupt M.Effects of treatments on the mortality of Stevens-Johnson syndrome andtoxic epidermal necrolysis: a retrospective study on patients included inthe prospective EuroSCAR Study. J Am Acad Dermatol 2008; 58:33-40.
14. Ghislain PD, Roujeau JC. Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome.Dermatol Online J 2002; 8:5.
15. Yang CY, Dao RL, Lee TJ, et al. Severe cutaneous adverse reactions toantiepileptic drugs in Asians. Neurology 2011; 77:2025-33.
16. Mauri-Hellweg D, Zanni M, Frei E, et al. Cross-reactivity of T cell linesand clones to beta-lactam antibiotics. J Immunol 1996; 157:1071-9.
17. Pichler WJ, Daubner B, Kawabata T. Drug hypersensitivity: flare-up reactions,cross-reactivity and multiple drug hypersensitivity. J Dermatol2011; 38:216-21.
18. Anne S, Reisman RE. Risk of administering cephalosporin antibiotics topatients with histories of penicillin allergy. Ann Allergy Asthma Immunol1995; 74:167-70.
19. Saxon A, Beall GN, Rohr AS, Adelman DC. Immediate hypersensitivityreactions to beta-lactam antibiotics. Ann Intern Med 1987; 107:204-15.
20. Phillips E, Louie M, Knowles SR, Simor AE, Oh PI. Cost- effectivenessanalysis of six strategies for cardiovascular surgery prophylaxis inpatients labeled penicillin allergic. Am J Health Syst Pharm 2000;57:339-45.
21. Antunez C, Blanca-Lopez N, Torres MJ, et al. Immediate allergic reactionsto cephalosporins: evaluation of cross-reactivity with a panel ofpenicillins and cephalosporins. J Allergy Clin Immunol 2006; 117:404-10.
22. Romano A, Viola M, Gueant-Rodriguez RM, Gaeta F, Pettinato R,Gueant JL. Imipenem in patients with immediate hypersensitivity topenicillins. N Engl J Med 2006; 354:2835-7.
23. Romano A, Viola M, Gueant-Rodriguez RM, Gaeta F, Valluzzi R,Gueant JL. Brief communication: tolerability of meropenem in patientswith IgE-mediated hypersensitivity to penicillins. Ann Intern Med2007; 146:266-9.
24. Atanaskovic-Markovic M, Gaeta F, Medjo B, Viola M, Nestorovic B, RomanoA. Tolerability of meropenem in children with IgE-mediated hypersensitivityto penicillins. Allergy 2008; 63:237-40.
25. Svetitsky S, Leibovici L, Paul M. Comparative efficacy and safety of vancomycinversus teicoplanin: systematic review and meta-analysis. AntimicrobAgents Chemother 2009; 53:4069-79.
26. Knudsen JD, Pedersen M. IgE-mediated reaction to vancomycin andteicoplanin after treatment with vancomycin. Scand J Infect Dis 1992;24:395-6.
27. McElrath MJ, Goldberg D, Neu HC. Allergic cross-reactivity of teicoplaninand vancomycin. Lancet 1986; 1:47.
28. Marshall C, Street A, Galbraith K. Glycopeptide-induced vasculitiscross-reactivity between vancomycin and teicoplanin. J Infect 1998;37:82-3.
29. Grek V, Andrien F, Collignon J, Fillet G. Allergic cross-reaction of teicoplaninand vancomycin. J Antimicrob Chemother 1991; 28:476-7.
30. Kwon HS, Chang YS, Jeong YY, et al. A case of hypersensitivity syndrometo both vancomycin and teicoplanin. J Korean Med Sci 2006;21:1108-10.
31. de Vries E, van Weel-Sipman MH, Vossen JM. A four-year-old childwith teicoplanin allergy but no evidence of cross-reaction with vancomycin.Pediatr Infect Dis J 1994; 13:167.
32. Macias E, Moreno E, Davila I, et al. Reaction to teicoplanin with toleranceto vancomycin. J Investig Allergol Clin Immunol 2008; 18:71-2.